UNH Stock Ownership Activity

UNITEDHEALTH GROUP INC 13F holders

11 value investing gurus have made changes to the UNITEDHEALTH GROUP INC (UNH) position according to the gurus' latest SEC quarterly report(s). UNH has been completely sold out by 1 guru(s), the number of UNH shares has been increased by 6, decreased by 4 super investor(s).

Which gurus or hedge funds are buying UNH now?

According to the latest SEC filing(s) UNITEDHEALTH GROUP INC (UNH) has been bought by 6 gurus, out of those top 5 purchases (by % change to portfolio) have been made by Ole Andreas Halvorsen - Viking Global Investors (added shares +195.41%), C.T. Fitzpatrick - Vulcan Value Partners (added shares +70.31%), David Rolfe - Wedgewood Partners (added shares +22.28%), Robert Olstein - Olstein Capital Management (added shares +93.33%) and David Katz - Matrix Advisors Value Fund (added shares +29.6%).

To see more about who is investing in UNITEDHEALTH GROUP INC (UNH), please go to the UNH ownership page.

2023 Q1 (12 results)
Daniel Loeb
-50.00%
-335,000
-2.59%
0.00%
David M. Polen
-0.48%
-13,041
-0.02%
3.38%
David Rolfe
+24.09%
+14,606
+1.17%
6.03%
Eric H. Schoenstein
-3.38%
-47,090
-0.17%
4.99%
Francois Rochon
-100.00%
-1,533
-0.06%
0.00%
Glenn Greenberg
-8.29%
-100
-0.00%
0.02%
John Armitage
-91.60%
-925,928
-4.97%
0.00%
Ole Andreas Halvorsen
+65.65%
+832,288
+1.85%
4.68%
Paul Lountzis
+7.03%
+577
+0.23%
2.46%
Ravenel Boykin Curry IV
-8.26%
-161,639
-0.39%
3.87%
Robert Olstein
+41.94%
+2,405
+0.24%
0.60%
Stephen Mandel
-16.21%
-172,433
-0.75%
3.90%
Current price: $521.35 10.37% AVG reported price*: $472.36
2022 Q4 (14 results)
Andrew R. Adams
-1.56%
-8,000
-0.10%
6.20%
David M. Polen
-4.35%
-119,580
-0.19%
4.07%
David Rolfe
-0.40%
-233
-0.02%
5.64%
Eric H. Schoenstein
+15.38%
+185,736
+0.77%
5.78%
Francois Rochon
buy
+1,533
+0.06%
0.00%
Glenn Greenberg
-51.09%
-1,260
-0.02%
0.02%
John Armitage
-7.44%
-49,574
-0.39%
2.82%
Ole Andreas Halvorsen
+263.71%
+919,153
+2.45%
3.38%
Paul Lountzis
+0.13%
+14
+0.00%
3.18%
Ravenel Boykin Curry IV
-24.94%
-726,183
-1.83%
5.49%
Robert Olstein
-10.92%
-950
-0.08%
0.64%
Ronald Muhlenkamp
+0.08%
+19
+0.00%
5.56%
Stephen Mandel
+13.21%
+124,144
+0.63%
5.38%
V. D. Dodge, E. M. Cox
-6.15%
-134,211
-0.09%
1.25%
Current price: $521.35 0.93% AVG reported price*: $526.27
2022 Q4 (1 result)
Ruane, Cunniff & Goldfarb
-17.06%
-79,350
-1.45%
7.03%
Current price: $521.35 1.67% Reported price*: $530.18
2022 Q3 (13 results)
Andrew R. Adams
-4.99%
-27,000
-0.32%
6.14%
Daniel Loeb
+17.54%
+98,500
+0.92%
6.05%
David M. Polen
-2.30%
-67,080
-0.09%
4.03%
David Rolfe
-2.59%
-1,117
-0.15%
3.99%
Eric H. Schoenstein
+8.41%
+93,674
+0.41%
5.31%
John Armitage
-23.23%
-347,821
-1.36%
4.51%
Ole Andreas Halvorsen
buy
+348,550
+0.82%
0.82%
Paul Lountzis
-2.33%
-168
-0.10%
2.41%
Ravenel Boykin Curry IV
+1.45%
+41,077
+0.10%
6.60%
Robert Olstein
-13.00%
-962
-0.11%
0.54%
Ronald Muhlenkamp
+0.86%
+212
+0.05%
5.58%
Stephen Mandel
+17.39%
+128,012
+0.66%
4.11%
V. D. Dodge, E. M. Cox
-2.97%
-73,900
-0.05%
1.57%
Current price: $521.35 3.23% AVG reported price*: $505.04
40 of 442

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.